Intellia Therapeutics
NTLA
#5607
Rank
A$2.05 B
Marketcap
A$14.63
Share price
1.65%
Change (1 day)
12.73%
Change (1 year)

Earnings for Intellia Therapeutics (NTLA)

Earnings in 2026 (TTM): -A$0.59 Billion

According to Intellia Therapeutics's latest financial reports the company's current earnings are A$59.5 Million. In 2025 the company made an earning of -A$0.62 Billion, an increase over its 2024 earnings that were of -A$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intellia Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.59 Billion-3.74%
2025 -A$0.62 Billion-20.49%
2024 -A$0.78 Billion7.86%
2023 -A$0.72 Billion1.48%
2022 -A$0.71 Billion77.01%
2021 -A$0.4 Billion99.58%
2020 -A$0.2 Billion34.86%
2019 -A$0.15 Billion16.63%
2018 -A$0.13 Billion26.35%
2017 -A$0.11 Billion113.51%
2016 -A$46.95 Million135.92%
2015 -A$19.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-60.96%๐Ÿ‡บ๐Ÿ‡ธ USA